CCL2 and neoplasm: Another study used mNOX-E36, a chemokine C-C motif ligand 2 (CCL2) inhibitor, to block TAM recruitment and angiogenesis in CLL2-expressing rat GBM models, which ultimately decreased tumour volume [53].